Tempus AI, Inc. (TEM)
NASDAQ: TEM · Real-Time Price · USD
84.49
-4.22 (-4.76%)
At close: Nov 4, 2025, 4:00 PM EST
79.40
-5.09 (-6.02%)
After-hours: Nov 4, 2025, 7:59 PM EST
Tempus AI Employees
Tempus AI had 2,400 employees as of December 31, 2024. The number of employees increased by 100 or 4.35% compared to the previous year.
Employees
2,400
Change (1Y)
100
Growth (1Y)
4.35%
Revenue / Employee
$460,524
Profits / Employee
-$84,948
Market Cap
14.68B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,400 | 100 | 4.35% |
| Dec 31, 2023 | 2,300 | 348 | 17.83% |
| Dec 31, 2022 | 1,952 | 385 | 24.57% |
| Dec 31, 2021 | 1,567 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TEM News
- 7 hours ago - Tempus AI, Inc. (TEM) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 10 hours ago - Tempus Reports Third Quarter 2025 Results - Business Wire
- 7 days ago - Tempus to Participate in the Stifel 2025 Healthcare Conference - Business Wire
- 14 days ago - Tempus to Report Third Quarter 2025 Financial Results on November 4 - Business Wire
- 15 days ago - Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity - Business Wire
- 19 days ago - Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research - Business Wire
- 20 days ago - Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025 - Business Wire
- 26 days ago - Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy - Business Wire